Nitrite plasma levels in normolipemic and hypercholesterolemic arteriopathics after vasoactive and lipid-lowering treatment

Panminerva Medica

Volumn 41, Issue 3, 1999, Pages 239-242

  Ferlito, S ^b,c   Gallina, M ^b   Catassi, S ^a   Bisicchia, A ^a   Di Salvo, M ^a  

^a Ferrarotto Hospital   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

^c NONE   (Italy)

Author keywords

Arterial occlusive diseases; Cholesterol; Endothelins; Nitrites; Peripheral vascular diseases; Simvastatin

Indexed keywords

ANTILIPEMIC AGENT; FIBRINOLYTIC AGENT; LIPID; NITRITE;

AGED; ARTERY; ARTICLE; BLOOD; DIET THERAPY; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; MALE; MIDDLE AGED; REFERENCE VALUE; VASCULAR DISEASE;

AGED; ANTILIPEMIC AGENTS; ARTERIES; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; HYPERCHOLESTEROLEMIA; LIPIDS; MALE; MIDDLE AGED; NITRITES; REFERENCE VALUES; VASCULAR DISEASES;

EID: 0033192330     PISSN: 00310808     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Zeiher AM, Drexler H, Saurbier B, Just H. Endothelium-mediated coronary blood flow modulation in humans: effects of age, atherosclerosis, hypercholesterolemia and hypertension. J Clin Invest 1993;92:652-62.
2. Chowienczyk PJ, Watts GF, Cockroft JR, Ritter JM. Impaired endothelium-dependent vasodilation of forearm resistance vessels in hypercholesterolemia. Lancet 1992;340:1430-2.
3. Egashira K, Inou T, Yamada A, Hirooka Y, Maruoka Y, Takashita A. Impaired coronary blood flow response to acetylcholine in patients with coronary risk factors and proximal atherosclerotic lesions. J Clin Invest 1993;91:29-37.
4. Creager MA, Cooke JP, Mendelsohn ME, Gallagher SJ, Coleman SM, Loscalzo J et al. Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. J Clin Invest 1990;86:228-34.
5. Drury J, Cohen JD, Veerendrababu B, Flaker G, Donohue TJ, Labovitz AJ. Brachial artery endothelium-dependent vasodilation in patients enrolled in the Cholesterol Abd Current Events (Care) Study. Circulation 1996;94:I-402.
6. Egashira K, Hirooka Y, Kai H, Sugimachi M, Suzuki S, Inou T et al. Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia. Circulation 1994;89:2519-24.
7. Treasure CB, Klein JL, Weintraub WS, Talley JD, Stillabower ME, Kosinski AS et al. Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease N Engl J Med 1995;332:481-7.
8. O'Driscoll G, Green D, Taylor R. Simvastatin, an HMG-Coenzyme A reductase inhibitor, improves endothelial function within 1 month. Circulation 1997;95:1126-32.
9. Leung WH, Lau CP, Wong CK. Beneficial effect of cholesterol-lowering therapy on coronary endothelium-dependent relaxation in hypercholesterolemic patients. Lancet 1993;341:1496-500.
10. Stroes ES, Koomans HA, de Bruin TW, Rabelink TJ. Vascular function in the forearm of hypercholesterolemic patients off and on lipid-lowering medication. Lancet 1995;346:467-71.
11. Ferlito S, Gallina M. Nitrite plasma levels in type 1 and 2 diabetics with and without complications. Panmin Med 1998, in press.
12. Ferlito S, Gallina M. Nitrite plasma levels in acute and chronic coronary heart disease. Minerva Cardioangiol 1997;45:553-8.
13. Gutman W, Hollywood CA. Simple, rapid method for the determining nitrates and nitrites in fluids. Clin Chem 1992;38:2152.
14. Boger RH, Bode Boger SM, Thiele W, Junker W, Alexander K, Frolich JC. Biochemical evidence for impaired nitric oxide synthesis in patients with peripheral arterial occlusive disease. Circulation 1997;95:2068-74.
15. Bode Boger SM, Boger RH, Alfke H, Heinzel D, Tsikas D, Creutzig A et al. L-arginine induces nitric oxide-dependent vasodilation in patients with critical limb ischemia: a randomized, controlled study. Circulation 1996;93:85-90.